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 1.0 Summary  
 
Title: DIAGNOSTIC CRITERIA FOR EARLY ONSET NEONATAL SEPSIS 
 
Author: Branimir Klobučar 
 
Neonatal sepsis is one of the leading causes of neonatal mortality worldwide. 
Unlike in the adult population, there is a large variability in the clinical picture and 
therefore the difficulty to recognize and diagnose neonatal sepsis. In addition to this, 
there is a lack of clear diagnostic criteria that would aide clinicians in diagnosis and rapid 
treatment of sepsis. There has been much ongoing research in this area without any 
striking success.  
Neonatal sepsis can be divided into different categories based on the age of 
disease onset. Early onset neonatal sepsis occurs in the first 72 hours of the child’s life 
and is associated with various risk factors and physiological differences when compared 
to other age groups. The risk factors may be related to the mother, the child, or the 
process of delivery.  
Early onset neonatal sepsis also has a specific set of pathogens that are most likely 
to cause disease. The two most common pathogens, E. coli and Group B streptococcus, 
have a tendency to exploit the neonates immature immune system resulting in possible 
complications. Several components of the neonates’ physiological inflammatory response 
have been researched for their value in diagnosis. The current evidence for C-reactive 
protein, procalcitonin, interleukin-6 and several other inflammatory reactants have shown 
variable results. The lack of a clear biomarker that would consistently confirm or exclude 
the diagnosis of neonatal sepsis continues to elude us. The continued exploration into the 
various markers and their combinations still needs to be researched so that a list of 
criteria can be developed in order to reduce the devastating results of the disease.  
Keywords: Sepsis, Early-onset sepsis, newborn, diagnosis  
 
 2.0 Sažetak 
 
Naslov: DIJAGNOSTIČKI KRITERIJI ZA RANU NOVOROĐENAČKU SEPSU 
 
Pisac: Branimir Klobučar 
 
Sepsa je jedan od vodećih uzroka smrtnosti novorođenčadi širom svijeta. U 
usporedbi sa odraslom populacijom, u novorođenčadi je klinička slika sepse 
nespecifična i šarolika. Zbog toga je rano prepoznavanje novorođenačke sepse 
uvelike otežano. Pored toga, nedostaju jasni dijagnostički kriteriji koji bi omogucili 
ispravnu i brzu dijagnozu sepse. Ovaj problem predmetom je konstantnog 
istraživanja, zasad  bez nekog znatnijeg uspjeha.  
Novorođenačka sepsa može se podijeliti u različite kategorije ovisno o 
vremenu pojavljivanja bolesti. Rana novorođenačka sepsa javlja se u prvih 
sedamdeset i dva sata života i povezana je s različitim rizičnim čimbenicima i 
razlikuje se od sepse u drugim dobnim skupinama. Čimbenici rizika mogu biti 
povezani s majkom, novorođenčetom ili s procesom rađanja.  
Rana novorođenačka sepsa također ima specifičan skup patogena kao 
najvjerojatnije uzročnike. Dva patogena, Escherichia coli i Streptococcus B skupine, 
najčešći su uzročnici rane novorođenačke sepse.  
Neke osobitosti upalne reakcije novorođenčadi istraživane su s ciljem 
vrijednovanja u postavljanju dijagnoze. Istraživanja o dijagnostičkoj vrijednosti C-
reaktivnog proteina, procalcitonina, interleukina-6 i nekoliko drugih upalnih 
reaktanata pokazala su različite rezultate. Još uvijek nije nađen biljeg koji bi 
dosljedno potvrdio ili isključio dijagnozu sepse u novorođenčadi. Neophodno je 
nastaviti istraživanja te pronaći dijagnostičke alate čime bi se  omogućilo pouzdano i 
pravovremeno postavljanje dijagnoze ove opake bolesti. 
 
Ključne riječi: sepsa, rana novorođenčka sepsa, novorođenče, dijagnoza
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3.0 Introduction  
 
This review will be geared towards the difficulties that come along with the 
diagnosis of early onset neonatal sepsis (EOS).  Clinicians have long been able to have a 
clear definition of sepsis in adults. Having a clear definition enables the physicians to 
administer the proper treatment as soon as possible, improving the patients’ chance of 
survival. This also avoids the overuse of antibiotics in patients where sepsis is not the 
correct diagnosis. Overuse of antibiotic therapy is a growing concern throughout the 
world; avoiding their unnecessary use can halt the inevitable resistance bacteria will 
develop to antibiotics. Unfortunately, clear diagnostic criteria are unavailable to the 
neonatal population. The clinical signs and symptoms of EOS are none specific and 
inconsistent making it difficult for a clinician to make a diagnosis (1). Due to this 
challenge, this review will focus on the most common and highly researched components 
in early onset neonatal sepsis that may assist the clinician in the process of diagnosis.  
 
4.0 Classifications and Definition  
 
Sepsis can occur at any age, but it is in the youngest and oldest age groups of the 
population where a fatal outcome is a frightening reality. It is important that the definition 
of sepsis is clear and consistent, enabling clinicians and researchers to be on the same 
page discussing its identification and treatment. Generally sepsis is defined as severe 
inflammatory response syndrome (SIRS) with confirmed infection. SIRS is the general 
body inflammatory response that typically leads to physiological alterations from 
baseline in the absence of a known cause. Body temperature >38 or < 36 degrees Celsius, 
tachycardia and mean respiratory rate >2 SD relative to age and leukocyte count elevated 
or suppressed for the relative age are all features of SIRS. SIRS can be a systemic 
reaction to several different causes that can be either infectious or non-infectious. Sepsis 
can progress further, being then classified as severe sepsis. Severe sepsis is the 
combination of sepsis with either organ dysfunction; hypoperfusion abnormality or sepsis 
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induced hypotension. Sepsis can progress as far as septic shock, which is defined as 
sepsis induced hypotension persisting despite adequate fluid resuscitation (2).  
Due to the physiological differences between adults and the pediatric population 
the definitions of SIRS, severe sepsis and septic shock have been altered. For children 
less than a year of age the definition of SIRS would be considered with the presence of 
bradycardia or tachycardia (3). It must also be taken into consideration that there is the 
absence of any external stimulation, congenital malformations or an unexplained 
depressed heart rate for over a 30 min period. Severe sepsis is defined as sepsis in the 
presence of cardiovascular organ dysfunction, acute respiratory distress syndrome or two 
or more other organ system dysfunctions such as hepatic, renal, neurological and 
hematologic. Septic shock in children does not require observable hypotension to make a 
diagnosis as it does in adults. Shock may occur long before hypotension sets in, and as a 
result septic shock in children is defined as tachycardia with signs of decreased perfusion. 
Due to the high levels of overlapping criteria, septic shock in children is considered as 
sepsis with cardiovascular dysfunction (3). 
 
The terminology defining the age of a child can become quite confusing and often 
terms are mixed and interchanged. Due to the focus of this paper, it is important to define 
the age group of interest. According to an international consensus done on June 8
th
 2010 
at the European medical association, the term “neonate” is classified for children < 1 
month of age. The term “infant” is reserved for children between 1 month and 2 years, 
whereas children greater then this age fall into categories defined as toddlers, preschool 
children, school age children and adolescents (4). The term “neonatal sepsis” is reserved 
for sepsis that occurs in newborns up to 28 days of life. Neonatal sepsis can be further 
divided into early and late. The classification between early and late neonatal sepsis has 
had several different definitions throughout time due to the unfamiliarity of where one 
would end and the other begin. The most widely used definition of early onset neonatal 
sepsis is sepsis that occurs within the first 72 hours after birth. Onset of sepsis between 72 
hours and 7 days of life would be defined as late onset neonatal sepsis (5). Some 
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literature defines early neonatal sepsis occurring less then or equal to 4 days of life and 
late neonatal sepsis up to 120 days of life (6, 7). Some authors have also gone further to 
divided neonatal sepsis into 3 separate categories opposed to the more common 2 
categories of early and late. EOS occurring within the first 4 days, LOS between 5 and 30 
days and “late, late onset neonatal sepsis” occurring on or beyond the 30th day of life (8). 
EOS also can have a wider time range defined as positive microbiological cultures within 
the first 7 days of life (9). Making the distinction between early and late onset neonatal 
sepsis (LOS) is an important one due to the difference in pathogens, modes of treatment 
and risk factors that are more frequently associated with each type of sepsis.  
 
5.0 Epidemiology 
 
Neonatal sepsis continues to be a heavy burden on the world’s health care and a 
major cause of neonatal death worldwide. It has been estimated that 36% of the worlds 4 
million neonatal deaths are a direct result of invasive neonatal infections, with most of 
these cases occurring in low and middle-income countries (10). The risk of neonatal 
mortality due to infections in low-income countries has been estimated to be 11 times 
higher then that of high-income countries (11). Only approximately 3.6% of the neonatal 
deaths due to infections occurred in high-income countries and still in 2007 it was 
established that neonatal sepsis was one of the top ten causes of infant mortality in the 
United States (12, 13). It is estimated that incidence rate of EOS ranges from 0.77 to 1 for 
every 1000 births in the United States. However, when we divide neonates into different 
categories based on birth weight (<1500g) and gestational age (<32 weeks) we see a rise 
in the incidence rate to 25 per 1000 and 8 per 1000 births respectively. Selected 
populations are also at an increased risk, as is seen in black preterm infants who hold the 
highest incidence of infection (5.14/1000 live births) and mortality (24.4% case fatality 
ratio) (5).   
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6.0 Pathophysiology  
 
Sepsis is a systemic inflammatory reaction of the body to an infectious 
microorganism that can lead to septic shock and death. The body produces several 
different types of proinflammatory cytokines in attempt to protect itself. However when 
the pathogen is in the victims’ blood, the body response is usually an overreaction that 
continually proves to be detrimental. The process begins by the bacterial agent entering 
the circulatory system and interacting with the complement cascade causing the release of 
several proinflammatory mediators such as C3 and C5a. These mediators cause vessel 
vasodilation and a release of proinflammatory cytokines such as interleukin-1, 6 and 8 
(IL-1-6-8) (14). These cytokines facilitate the adhesion of leukocytes to the endothelial 
wall, releasing nitric oxide and reactive oxygen species that then cause injury to the 
endothelial cell wall. This cell injury coupled with vessel vasodilation leads to leakage of 
the fluid into interstitial space (15). In addition to vessel vasodilation the bacterial antigen 
can facilitate the formation of microthrombi in the microcirculation, further 
compromising tissue perfusion (14).  
The majority of the complications associated with bacteremia are due to the lack 
of counterbalance in proinflammatory cytokines. The immaturity of the neonates immune 
system fails to produce adequate anti-inflammatory cytokines (14). Due to this 
immaturity of the immune system compared to adults, they have an increased rate of 
infections (16). Neonates are also not able to proficiently combat the effects of the 
polymicrobial flora that they are exposed to during and after birth. It is therefore during 
this period their major source of defense against any pathogen is their innate immunity 
and the passive protection that is acquired in utero from their mothers (17).  
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7.0 Etiopathogenesis  
 7.1 Risk Factors 
 Neonatal sepsis can be the result of a wide range of microorganisms with several 
different routes of transmission. EOS and LOS not only differ in the timeline in which 
infection occurs, but also on the organisms and routes of entry. Sepsis that occurs in the 
early days of the neonates’ life can be due to factors related to the mother or the child. 
Maternal factors have shown to be of great influence to the development of EOS. The 
child can be affected by maternal factors either when it is in the uterus or during the 
process of birth. Throughout her pregnancy the mother can be exposed to several 
different procedures, all of which carry some risk of harming the child. A procedure such 
as amniocentesis is no exception; it is a procedure that is frequently used for diagnostic 
purposes concerning the development of the fetus. It carries a risk of exposing the fetus to 
microbial agents within the uterus (18). The mother’s dietary habits prior to labor or 
delivery can also put the infant at risk for certain microbial agents that contaminate food 
(5). One of the maternal risk factors that have been heavily studied is prolonged rupture 
of membranes (PROM). This is a condition of pregnancy where there is a rupture of the 
amniotic sac prior to the onset of labor and can occur at any gestational age. It is defined 
as the rupture of the membranes longer than 24 hours before delivery and carries the 
increased risk of ascending infection which can put both the mother and child at risk (19). 
In developed countries such as the United States, PROM complicates approximately 3% 
of all pregnancies (20).   
 Several studies have also presented the case of fever in the mother and child 
induced by epidural analgesia. It can pose as a risk factor in the development of neonatal 
sepsis. It appears that the increased frequency of neonatal sepsis evaluation and treatment 
occurred more often in children of mothers receiving epidural analgesia compared to 
those that did not (21). A maternal fever that is greater then 38 degrees Celsius usually 
prompts the clinicians to evaluate the infant for sepsis and as a result may lead to the 
unnecessary administration of antibiotics (22). Vaginal colonization of group B 
streptococcus (GBS) is a common occurrence. The source of maternal colonization often 
occurs from the gastrointestinal tract. Some women may present with subtle urinary tract 
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related symptoms; however, the vast majority is asymptomatic. A strong link between 
EOS and maternal colonization has been seen over the years, raising considerable 
investigation into the subject (23). Chorioamnionitis (CAM) is a bacterial infection that 
results in the inflammation of the fetal membranes, which consists of the amnion and the 
chorion (24).  CAM is defined as a group of signs consisting of maternal fever, maternal-
fetal tachycardia, uterine tenderness, foul odor of amniotic fluid and leukocytosis of  >15 
000 WBC/mm
3
 and is considered a strong risk factor for the development of neonatal 
sepsis (5). CAM complicates approximately 1 to 4% of all pregnancies in the United 
States, however its frequency varies with the diagnostic criteria used, associated risk 
factors and gestational age. Up to 70% of preterm births and 13% term births are 
complicated by CAM (25).  
 Several important and well-studied risk factors are related to the development of 
the infant. Preterm birth is defined as any births that occur before the 37
th
 completed 
week of gestation. We can further classify preterm birth into moderately preterm (33-36 
completed weeks), very preterm (<32 weeks) and extremely preterm (<28 weeks). 
Several factors can contribute to increased values of preterm births, especially in high-
income countries with rigorous caesarian policies implemented to reduce still birth rate, 
therefore artificially increasing preterm birth rate (26). In 2005 the Lancet published that 
preterm birth rates (percentage of births before 37 weeks) accounted for 28% of all 
neonatal deaths, slightly above the 27% of deaths directly due to neonatal sepsis and 
pneumonia (11). Not only is preterm birth one of the leading direct causes of neonatal 
death, it is also a leading risk factor for neonatal deaths due to infection. Complications 
that increase the risk of a preterm infant to infection are related to its immature immune 
system. Due to the fact that the child has less time to develop in the mothers’ womb, it is 
also susceptible to missing the period in which passive immunity from the mother is 
acquired. Preterm birth is not always the cause of increased risk to developing infection, 
but also can be a result of another unidentified problem, such as systemic inflammation or 
congenital abnormalities (26). Another factor that is highly connected with preterm birth 
is a low birth weight. Reduced infant birth weight is usually a result of preterm birth or 
restricted intrauterine growth (11). It can be categorized according to the birth weight of 
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the child into low birth weight (<2500g), very low birth weight (<1500) and extremely 
low birth weight (<1000g) (27). Low birth weight is a common concern throughout the 
globe as approximately 18 million births fall under 2500g each year. Even if it 
contributes to 14% of all births, 60-80% of all neonatal deaths are in this low birth weight 
category (11). The highest proportion of low birth weights are in South Asia (28%) and 
the lowest occurring in industrialized countries (7%) (27). Both preterm and low birth 
weight are the risk factors most closely associated with EOS and therefore it is important 
we take a closer look into their usefulness in predicting neonatal sepsis (28).   
7.2 Pathogens  
 Just like the risk factors between EOS and LOS differ, the pathogens that result in 
infection also differentiate. The route of infection for EOS typically tends to occur either 
through vertical transmission in utero, during birth (perinatal infections) and through 
breast feeding (postnatal infections) (14). The two most common pathogens making up 
70% of all the early neonatal infections are Streptococcus group B (GBS) and E. coli (5, 
14). Other less common pathogens making up the final 30% are other streptococci 
(Viridians and pneumonia), Staphylococcus aureus, Enterococcus, H. influenzae 
(excluding group B) and Listeria monocytogenes (14).   
  Sepsis caused by GBS in the early neonatal period consists of approximately 47% 
of all neonatal infections (14). According to a collection of data between the year 2005 
and 2008 it was shown that EOS due to GBS was 0.77 cases for every 1000 live births. 
The vast majority of EOS cases due to GBS also tend to occur more often in term 
neonates (73%) (29). Pregnant woman who are colonized with GBS tend to be 
asymptomatic. African American, < 20 years of age, low parity and diabetic woman have 
a higher degree of susceptibility to colonization by GBS when compared to the rest of the 
population (30). The 12.1% mortality rate in EOS due to GBS was almost double that of 
LOS which was only 6.8% (31). Neonates who are infected with GBS are also at a high 
risk of developing persistent pulmonary hypertension (PPH). This condition is associated 
with a high neonatal mortality rate of 10 to 20% (32). Children suspected of having acute 
respiratory syndrome through imaging must be investigated for possible GBS infection. 
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Due to the increase in evidence of neonatal sepsis and maternal colonization of GBS, 
prophylactic antibiotic therapy has become a common practice. This has translated to a 
reduction in the incidence of EOS caused by GBS; however, at the same time has risen 
concern with the possible increase in resistance in ampicillin-resistant E. coli over time 
(5, 14). 
 The second most frequent pathogen, attributing to approximately 23% of the EOS 
cases and 81% of all preterm cases is E. coli. This relationship appears to be even 
stronger when looking at VLBW neonates (33). Like GBS, E. coli is also another microbe 
that populates the mucosa of the vaginal canal. Most of the neonatal infections are 
acquired during passage through the canal or just before delivery. Even if the incidence of 
infection due to E. coli is lower when compared to GBS, the percentage of deaths from E. 
coli is much greater. When taking into account both E. Coli and ampicillin-resistant E. 
coli, the case fatality rate (CFR) found in a surveillance program from 2005-2008 was 
22.9%. This is significantly greater when compared to the CFR of GBS, which was 6.8% 
(29). Figure 1 below shows the reduction in the incidence rate in EOS due to GBS over a 
10-year period.  
 
Figure 1. GBS and E. coli early onset sepsis annual cumulative incidence per 1000 late preterm 
NICU admissions between 1997 and 2007 (7).  
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8.0 Diagnostics  
 8.1 Clinical Presentation  
Table 1 below displays the normal vital sign values of a child depending on their 
age. However, not only do the values vary according to age, they also change with the 
neonate’s weight. In 2008 the hemodynamic consensus depicted different mean blood 
pressure (MBP) values for children between 1 to 3 days of age, their weight and their 
gestational age (GA). ELBW who were between 23-27 weeks of gestation neonates had a 
MBP equal or higher than their GA. Neonates with VLBW and GA of 28-33 weeks had a 
normal MBP value of > 30 mmHg and LBW children with a GA 34-37 weeks had normal 
values > 35. Term and normal weight neonates had normal values > 40 mmHg (15). The 
clinical presentation of a newborn child can be very difficult to identify and as a result, 
diagnose. The clinical presentations can vary between preterm, term, low birth weight 
neonates and type of pathogen involved. Symptoms also vary by being broad and 
unspecific making the physicians task that much more difficult. Delayed weight gain, 
pale skin, lowered tone, reduced movements, reduced crying and reduced eating all are 
common features. Body temperature tends to fluctuate and can be high, low or even 
normal, and therefore making it difficult to use to detect a diagnosis. Sepsis being a 
systemic disease can result in symptoms of any organ system. Determining the system 
that is being affected can also prove to be of great value to localize possible source and 
the likely pathogen. 
 
Table 1: Vital signs for Age specific groups. Modified from International Consensus 
Conference on Pediatric Sepsis. International pediatric sepsis consensus: definition for 
sepsis and organ dysfunction in pediatrics (3) 
Age Group  Heart Rate (bpm) 
Respiratory Rate 
(breaths/min) 
Systolic Blood 
Pressure (mmHg) 
0 to 7 days 100 to 180 >50 <65 
7 to 28 days 100 to 180 >40 <75 
1 mo to 12mo  90 to 180 >34 <100 
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Changes in the newborns arousability, sunken or bulging fontanelle, reduced 
femoral pulse and seizures can point to neurological involvement. Nausea, vomiting 
abdominal distention can direct the physician to a gastrointestinal cause. It is important to 
also observe skin changes due to their common occurrence. Cutaneous and mucosal 
petechiae, impetigo, cellulitis, infections in and around the umbilicus and abscesses can 
all be observed. Other more general symptoms such as metabolic acidosis, jaundice 
hypoglycemia, hyperglycemia may be due to the metabolic alterations of the neonate (9). 
Being aware of any possible clinical signs and symptoms that result form neonatal sepsis 
is important to recognize so that investigation into the child’s status can be initiated.  
8.2 Laboratory 
In the diagnostic process, laboratory analysis has become a critical part in our 
decision-making. In neonatal sepsis this has been an area of ongoing debate and research. 
For the most part, results have been unclear and a single perfect diagnostic tool has yet to 
be discovered. The absolute best marker for diagnosis would have to contain high 
sensitivity, specificity, positive predictive value and negative predictive value (34). 
Taking this into consideration, there have been many different diagnostic markers 
researched that may be used in combination in order to assist in diagnosis.  
The gold standard for a definitive diagnosis is a blood culture. However, there are 
many problems with this test that reduces its value. Blood cultures can take as long as 48-
72 hours making them an unreliable tool in determining if treatment is needed in the 
critical hours once the disease has begun. They also lack a high positive predictive value 
with less than 50% of the cases being positive. In suspected cases, blood cultures should 
still be taken before antibiotic therapy is initiated. The results of the cultures should then 
guide further treatment for usage of narrow spectrum antibiotics, further assessment or 
discontinuation of treatment (14).  
Blood tests are routinely done for virtually all diseases including neonatal sepsis. 
There has been an increase in their use for the screening of neonates with suspected cases 
of sepsis. According to a study published in 1988 Rodwell et al, a hematological scoring 
system was developed in order to assist in the early diagnosis and treatment of neonatal 
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sepsis (35). Immature to total neutrophil ratio (I:T), immature to mature neutrophil ratio 
(I:M), total polymorphonuclear leukocytes (PMN) count, immature PMN count, 
degenerative changes in PMNs and platelet count were the parameters included in the 
scoring system. Each of the parameters contributes a point in the overall score. A score > 
2 would indicate the increased likelihood of sepsis, whereas a score ≤ 2 would point to 
almost certainty of the absence of sepsis (35). This would be an ideal system if it 
predicted sepsis with a high accuracy. However, the scoring system had a weak positive 
predictive value and inconsistent sensitivity and specificity make it unreliable as a soul 
indicator for treatment and diagnosis. Levels of neutrophils vary considerably in children 
depending on their gestational age, birth weight, age in hours and various other maternal, 
intrapartum and perinatal factors (36). Blood results overall tend to have a high negative 
predictive values but poor positive predictive values (5).  
Biological markers have emerged as the most researched area in the journey to 
find a perfect test. Two acute phase proteins, C-reactive protein (CRP) and procalcitonin 
(PCT), are among those heavily researched. CRP is a peptide that is synthesized in the 
liver in response to an infection or the inflammatory process. Its levels rise within the 
first 6 to 8 hours and peaking at the 24
th
 hour (5). With a half-life of 24-48 hours, CRP 
has the best predictive value with serial measurements when compared to individual 
measurements (34). PCT levels in the blood rise as quickly as 2-4 hours after exposure 
and can peak between 6-8 hours (34). It is a peptide produced in liver cells and 
monocytes with a half-life of about 24 hours. Its normal values in a neonate younger then 
72 hours are usually < 0.1 ng/liter. However, there is a normal physiological elevation 
that occurs in the first 24 hours after birth, possibly resulting in confusion during result 
interpretation. Its levels are more likely to be elevated due to bacterial infections and tend 
to decrease as a response to treatment. Promising studies have show the PCT levels can 
be of use and is being increasingly used in the real-time guidance of therapy (5).  
The inflammatory response of the body to a foreign antigen results in the 
production of cytokines. Cytokines are small peptides that are produced by the body’s 
immune cells. They act on other cells in the body, further amplifying the inflammatory 
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response. Interleukin-6 and 8 are produced by leukocytes and act on other leukocytes 
(37). The release of IL-6 results in the production of CRP and has thus raised interest as a 
possible early detector in neonatal sepsis (38). IL-6 has a very short half-life and falls 
quickly to undetectable levels once treatment is initiated, and as a result to this quick drop 
in serum levels, the sensitivity of IL-6 as a marker drops from 67% to 58% from 24 to 
48h hours after infection (39). IL-8 is produced in response to polysaccharides, TNF and 
IL-1. It was found to increase proportionally to the severity of the infection, giving it 
value in the early detection (40). Tumor necrosis factor-alpha (TNF-α) is another pro-
inflammatory cytokine that has been known to have a role in activation of several other 
inflammatory pathways and as a result studied to find a possible role in neonatal sepsis 
(41). It has similar kinetic to IL-6 and has found to have been higher in groups with 
confirmed sepsis versus the controls (41, 42). Even with promising data, research on 
TNF-α and as diagnostic marker in sepsis has been limited. In addition to cytokines, 
certain soluble cell surface antigens have been researched. CD64 is found on 
macrophages and monocytes and binds IgG antibodies with a high affinity. Its expression 
is known to be increased in the presence of other inflammatory cytokines like INF-γ (43, 
44). Due to the costly procedures required to obtain values for CD64, it is likely an 
unreliable method of diagnosis. It has been suggested that many laboratories may not be 
willing to perform such tests individually and rather in batches, defeating the purpose of 
quick testing to diagnose sepsis (45). 
CD11β is a α-subunit of an adhesion molecule involved in neutrophil adhesion, 
diapedesis and phagocytosis. The molecule is located at very low levels on the surface of 
neutrophils, with the majority located in granules (46). Upon interaction with a foreign 
pathogen an increased expression occurs in a very short period of time. Its expression is 
also influenced by IL-8, a strong neutrophil activating agent (47). Compared to adults, a 
newborn show reduced ability to enhance CD11β expression due to lower levels located 
in granules (46). Even with reduced levels compared to adults, CD11β levels are 
detectable within the first 5 min of a bacterial infection and peak within 30 minutes (48, 
49). It was observed in the first day of life there was a 2-4 times increase in its expression 
on neutrophils in blood culture positive children, results which were also comparable to 
 13 
adults (50). Due to its quick increase at the onset of an infection, both IL-8 and CD11β 
have show promising results as reliable detectors of EOS.  
9.0 Discussion 
9.1 Risk Factors  
Maternal factor have a large influence on the developmental wellbeing of the 
child prior to, during and after birth. There has been difficulty in separating the risk 
factors for sepsis because of their high influence upon one another. PROM > 24 hours, 
CAM, maternal GBS colonization, gestational age, birth weight and maternal fever all 
have an impact on the risk of the child developing sepsis. Whether one has a greater 
influence on sepsis development over the other, is still an ongoing debate. Previous 
studies observed that the incidence of culture proven EOS was between 2.6% - 8.1% 
when premature rupture of membranes was the main risk factor studied (51). In a study 
by Alam et al, premature rupture was defined as >18 hours before birth. They found that 
neonates had a culture proven EOS rate of 4%. However, this was difficult to attribute 
solely to PROM due to the presence of maternal fever in 88% of the cases and CAM in 
77% of the cases. Other risk factors commonly associated with the children in this study 
were low birth weight (47%) and GA < 34 weeks (41%). Longer PROM of > 48 hours 
was identified in 41% of the septic neonates (51). Other studies showed an increased risk 
of sepsis when PROM present for > 48 hours. Seaward et al showed a 2.75-increased risk 
in neonatal infection when compared to PROM < 12 hours (52). A study conducted in 
Thailand had an incidence rate of sepsis in newborns follow PROM as high as 27.9%. 
However the diagnostic criteria for sepsis were wider in this study, which included 
culture negative neonates with signs and symptoms of sepsis (53). Linder et al had an 
incidence rate of sepsis in 8% of the neonates with PROM >24 hours. However ten out of 
the eleven children with sepsis were born prematurely, whereas the eleventh child was 
small for gestational age. Neonatal sepsis was found in 15% of premature infants with 
PROM (54). Monitoring of children for development of symptoms for 72 hours after 
birth should be practiced if born to mothers with PROM > 18 hours (53). 
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Children born to mother with PROM also have a high probability of other risk 
factor contributing to the development of neonatal sepsis. CAM appears to be a condition 
that parallels PROM. One of the risk factors for the development of CAM is in fact 
PROM (25). Both the Center for disease control (CDC) and the American academy of 
pediatrics (AAP) consider CAM as the second risk criterion in EOS (55). Some studies 
linked EOS to CAM using strict diagnostic criteria, with one or two clinical finding in 
addition to maternal fever (56). Whereas, in more recent studies the criteria of maternal 
fever is all that may be observed to conclude a diagnosis of CAM (57). This can lead to 
over diagnosis and overtreatment of both the mother and child, as women who receive 
epidurals have a higher likelihood of fever (21). Yancey et al found an overall relative 
risk of 4.4 in neonates who developed sepsis, born to mothers with CAM (58). However, 
these results often differ when studies differentiate the GA between infants born to 
mothers with CAM. Gestational ages ≥ 35 week showed a low correlation (0.47%-
1.24%), where children < 35 weeks showed rates ranging from 4.8%-16.9% (55). Other 
studies showed a high specificity (98%) and negative predictive value (98%) for CAM, 
but low sensitivities (14%) and positive predictive values (7%) (59). Due to the evidence 
presented, it is difficult to predict the probability of developing sepsis solely based on 
these risk factors. Both CAM and PROM can be influenced by other factors making them 
unreliable.  
Children born prior to the 37
th
 week of gestation carry with them a host of 
complications. The frequency of neonatal sepsis in preterm neonates occurs at a greater 
rate when compared to term neonates. Vergnano et al found that 82% of neonatal 
infections occurred in children born prior to the 37
th
 week, with 71% of those children 
being born with < 32 weeks of gestational (60). This was also found in another study 
considering children infected by E.coli. They concluded that children with a gestational 
age ≤ 33 weeks were at 26.5 times more likely of infection when compared to the 
controls (61). However it continues to be difficult to separate the maternal risk factors 
form one another. Preterm neonates also carry a higher likelihood of other maternal risk 
factors, which is apparent when the evidence is provided. As previously mentioned, 
clinical CAM occurs more frequently among women who deliver preterm babies versus 
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those that deliver term infants at a rate of 5.7% and 1.7% respectively (62).  
Table 2. Predictive power of clinical risk factors Modified from Flidel-Rimon et al(59), 
PPV- Positive predictive value, NPV-Negative Predictive Value 
 Sensitivity 
(%) 
Specificity 
(%) 
PPV       
(%) 
NPV       
(%) 
Prematurity < 37 weeks 28 48 0.7 98.1 
PROM >24 hr 14 62 0.5 98.2 
Maternal Fever ≥38°C 19 68 0.75 98.5 
Chorioamnionitis 14 98 7 98.9 
2 Risk Factors 28 79 1.7 98 
 
Schrag et al compared preterm infant with maternal risk factors such as PROM 
and fever and found an increased risk of infection of 5.2 and 7.4 respectively when 
compared with term infants with the same maternal risk factors (61). The table above 
shows the sensitivity, specificity, positive predictive value (PPV) and negative predictive 
value (NPV) of the major maternal risk factors associated with EOS in the population 
studied (59). In the absence of the risk factor there is high reliability in predicting the 
absence of neonatal infection, however none of the risk factors are reliable enough to 
predict neonatal sepsis. As mentioned before it is difficult to separate all the maternal risk 
factors because they often happen in parallel. More studies need to be conducted to 
evaluate each risk factor on their own. Until then it is best to use maternal risk factors as a 
tool to anticipate possible high-risk cases and to guide the need for further diagnostics.  
Vaginal colonization appears to be a more independent maternal risk factor when 
compared to the previous risk factors. Figure 1 shows an evident decline in the 
occurrence of GBS neonatal sepsis since the introduction of prophylactic antibiotic 
therapy in mothers colonized with GBS. As with any other maternal risk factor, preterm 
neonates have higher mortality rates from GBS infection (20%) when compared to term 
neonates (2%-3%) with an even higher mortality rate seen in preterm children ≤ 33 weeks 
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of gestation (30%) (63). Mother colonized with GBS were shown to be > 25 times more 
likely to give birth to early onset GBS disease. Without any intervention, colonized 
mothers would give birth to GBS infected children at a rate of 1%-2% (63, 64). In a 
collection of studies investigated by Verani et al, there was shown to be a high correlation 
with mothers that had positive GBS urine sample and neonatal infection (63). When 
taking into consideration other possible maternal risk factors, colonized mothers with no 
other maternal risk factors gave birth to GBS infected children at a rate of 5.1/1000 
births. Whereas mother not colonized with GBS and one other maternal risk factor gave 
birth to GBS infected children at a rate of 0.9/1000 births (64). In this time where we are 
more aware of GBS infections and the risk factors related to them, screening has become 
much more widespread. Due to this, now we see > 60% of all early onset GBS infections 
in mothers testing negative for GBS colonization. False-negatives are also common due 
to testing of mother between 35-37 weeks of gestation will miss some women with 
intrapartum colonization (63).  
Table 3 on the next page illustrates the rates of neonatal sepsis collected over a 
15-year period for both early and late depending on the newborn birth weight. It is 
evident that the rates of neonatal sepsis are higher in lower birth weight neonates, with 
onset occurring more frequently after the 4
th
 day of life. Even if the rates of neonatal 
sepsis are much lower in the first three days of life, there is a significant inverse 
correlation between birth weight and rate of EOS. Gram-negative organisms occur 51%-
53% of the time in LBW neonates with E.coli being the most frequent (65, 66).  
Table 3. Birth Weight-Specific Sepsis rates for Newborns. Table modified from Bizzaro 
et al.(8) EOS- Early onset neonatal sepsis, LOS- Late onset neonatal sepsis 
Birth weight (g) 
                      
Sepsis,  Cases /1000 
births 
 
 EOS (0-4 days) LOS (>4days) Total 
ELBW <1000 54.5 441.8 496.3 
VLBW 1000-1499 14.8 79.2 94 
LBW ≥1500 3.52 23.43 26.95 
Total 72.82 544.43 617.25 
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9.2 Laboratory  
9.2.1 Complete blood count  
Drawing of blood from neonates suspected of having sepsis has become a routine 
procedure. However, the information gathered can be difficult to interpret. White blood 
cell counts vary in the neonatal population depending on several different factors 
mentioned earlier. In term neonates, normal WBC count tend to peak between 12-14 
hours after birth, ranging between 7,800 and 14,500/mm
3
 (36). Several studies have been 
conducted assessing the total WBC count and absolute neutrophils counts (ANC) in 
relation to neonatal sepsis. Low values in both WBC count and ANC has been 
consistently associated with bacterial infection (38). In a study conducted by Hornik et al, 
WBC values < 5000/ mm
3
 and < 1000/ mm
3
 were found to have a high specificity in 
predicting the presence of infection, but with a poor sensitivity. The study also observed 
that subjects with normal WBC counts (5,000/ mm
3
 – 19,999 mm3) had positive blood 
cultures 60% of the time. However, when 4 different normal WBC counts were taken 
throughout the day, only 0.6% of the patients had positive blood cultures (67). These 
results are similar with an earlier study by Rodwell et al, who found low sensitivity and 
PPV values but a high specificity of 92% and a NPV of 94% (35). In addition to this, 
other studies observing higher cut off values (WBC count < 5,000 to 7,500 mm
3
) also 
found specificity values of 91%, but even lower sensitivity values of 29% (68).  In 
addition to WBC counts and ANC, I:T ratios have also shown similar results.  
Various cutoff ranges have been examined for I:T ratio for the diagnosis of sepsis 
in neonates. Typically the lowest cut off ratio considered is >0.2, as was done in a study 
that observed 150 neonates with clinical suspicion of sepsis. They found a high 
specificity and NPV as well as low sensitivity and PPV. Hornik et al also observed higher 
cut off values of >0.25 and >0.5, however only had success in further improving the 
specificity and NPV while seeing a drop in sensitivity and PPV (67). The same trend was 
presented in earlier studies conducted in 2000 with cut off values of ≥0.25 and ≥0.30 
(69). These results stayed consistent even when preterm neonates of <32 weeks were 
considered. Here they found that between 25% to 50% of the neonates had an elevated 
I:T ratio (70). It is evident that alone I:T ratio cannot prove neonatal sepsis. However, the 
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finding suggests that neonatal sepsis cannot be ruled out with an elevated I:T ratio (71).  
9.2.2 Biomarkers  
CRP is the highest researched biomarker in relation to the diagnosis of neonatal 
sepsis.  It is an acute phase protein that rises in response to the body’s inflammatory 
reaction. It is commonly used to monitor the progress and treatment of a disease in both 
the adult and pediatric population. Research considering the effectiveness of CRP in the 
diagnosis of EOS has been extensive. Wide ranges of cut off values have been 
considered, ranging from 0.2 to 95mg/L (41). The most frequently studied cut off value 
of 10mg/L has shown variable results. According to Meem et al. who reviewed a 
collection of 70 papers with the cut off range from 0.2 to 10 mg/L found that the 
specificity ranged 72% to 100% and a sensitivity range from 41% to 96% (41). Other 
studies not observed by Meem et al found sensitivity values as low as 9% for a cut off 
value of 10 mg/L (72). CRP had the most promising values between 24 and 48 hours (5).  
It is evident that if used alone, CRP can reliably exclude the diagnosis of sepsis. However 
due to its low sensitivity it is an unreliable factor to be used to confirm diagnosis. If 
measured serially it has shown strong evidence against bacterial sepsis and its use in the 
guidance of antimicrobial therapy (5).  
According to the research, PCT appears to have a generally better sensitivity 
when compared to CRP. In their comprehensive analysis of 100 studies, Meem et al 
found the mean sensitivity of PCT to be 77.9% and mean specificity 81.8% (41). When 
taking into consideration the cut-off values observed, higher values of >11pg/ml had a 
sensitivity as low as 21% compared to the lowest value of 58% found with cut-off values 
between 0.34 and 10 pg/ml (41). When specifically looking at EOS, Vouloumanou et al 
found a pooled sensitivity and specificity of 76%. They concluded that PCT has a very 
good diagnostic accuracy but seem to be somewhat better in LOS then in EOS. Although 
they used a lower range of cut-off vales when compared to Meem et al, there was no 
noticeable difference in the results (73). Even with improved sensitivity compared to 
CRP, PCT cannot identify 100% of septic neonates alone, making it more useful when 
used in combination with other markers and tests.  
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The research up until this point shows promising insight in to the diagnostic 
validity of interleukin-6 in the early phase of sepsis. However, its strength as the sole 
detector decreases rapidly due to its short half-life. Through various studies observed by 
Delanghe et al, the average sensitivity and specificity of IL-6 was 76% and 84% 
respectively. When only taking into consideration studies specifically geared towards 
EOS, the average specificity dropped to 71%, whereas the sensitivity remained the same 
(74). The previous studies considered took lower cutoff values for diagnosis even if 
higher levels of IL-6 have been found in children with proven sepsis (75). Two studies in 
which the cut off values of ≥100 pg/ml was used, had considerable variation in both their 
sensitivity and specificity ranging from 83.3% to 96% and 77% to 90.3% respectively. 
Both showed very good NPV of 97% or higher, but failed to show high PPV (76, 77). 
Due to the short half-life of IL-6, combining it with inflammatory markers with a longer 
half-life shows to improve its diagnostic validity. When combined with TNF-α in 
detection for EOS, there is an improvement in sensitivity compared to either of them 
alone (39). In 1994 de Bont et al observed an improvement of both sensitivity and 
specificity for both TNF-α and IL-6 from 60% to 100% when they are combined. 
Therefore claiming that when both are positive, the diagnosis of sepsis is almost certain 
(78). Later studies also found high sensitivity vales of 98.5%, PPV of 61% and NPV of 
90% with no reported values for specificity for the combination of IL-6 and TNF-α (79). 
When considered separately TNF-α had a mean sensitivity of 79% and specificity of 81% 
(41). Døllner et al found that combining both CRP and IL-6 also improved both the 
specificity and sensitivity of both when compared to each individually (80).  
Interleukin 8 is considered a highly accurate marker when predicting the presence 
of infection in early neonatal sepsis with sensitivity and specificity values ranging from 
80% to 90% and 76% to 100% respectively (42). However there have been several 
studies conducted finding a wider range of results. When choosing a cutoff value of 70 
pg/ml the sensitivity had a range from 44% to 92% and 70% to 90% for specificity. PPV 
and NPV values found in these studies ranged from 43% to 65% and 83% to 94% (81-
83). With a higher cutoff value of 300 pg/ml there was an increase in the sensitivity 
(91%), specificity (93%), PPV (91%) and NPV (97%) (84). However due to the small 
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sample size of this, more research need to be done with higher IL-8 cutoff values. When 
the combination of IL-8 and CRP was considered, they observed an improvement in their 
overall results. Sensitivity, PPV and NPV increased from 44% to 80%, 58% to 68% and 
83% to 93% respectively with the specificity remaining practically unchanged (81).  
Research on CD11β levels and its usefulness in diagnosis have been limited but 
promising. Various studies have also combined CD11β with IL-8 and CRP with positive 
results. Weirich et al were one of the first ones to study CD11β as a marker in neonatal 
sepsis. They found that serum CD11β was low in children in whom were later excluded 
for sepsis and that all the children with high levels were infected. Sensitivity and 
specificity were 96% and 100% respectively, with PPV and NPV 100% and 99% 
respectively. These neonates were suspected to have infection or were confirmed via 
blood culture. However, when only taking bacterial infections into account the specificity 
would drop to 81% and the PPV to 22% (46). Nupponen et al tested both CD11β and IL-
8 and finding that both are superior to CRP for detecting early infection in children with 
EOS. They found CD11β values of 100% for sensitivity and specificity and for IL-8 
having a sensitivity of 91% and a specificity of 100%. It is also interesting to note that in 
the study the authors found that the levels of IL-8 were higher in non-survivors when 
compared to survivors paralleling the finding of the previously discussed studies (47). 
The same values were not achieved by all the studies conducted at that time as 
Weinschenk et al. failed to show any elevation in CD11β levels in infected neonates (85). 
More recent studies conducted consistently found a rise in CD11β levels in septic 
newborns when compared to non-septic newborns and controls. High specificity of 100% 
and PPV of 100% were also found in the study by Adib et al. The sensitivity (75%) and 
NPV (86%) where also found to be 100% when combined with quantitative 
measurements of CRP (86). Similar results were also found in a study conducted in 2011, 
with improved sensitivity and specificity when CD11β was combined with CD64 and 
CRP (87). The most recent study from Norway conducted in 2016, used GBS III 
stimulation in vitro to test the rise in CD11β. They also found results similar to the others, 
with a specificity of 100% and sensitivity of 95% (88). Although promising, only a 
handful of studies have been conducted on the relationship between the levels of CD11β 
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and neonatal sepsis. More research needs to be conducted in order to establish a definitive 
relationship.  
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10.0 Conclusion 
  
 Early onset neonatal sepsis continues to be a devastating disease for the both the 
patient, family and the physician. The importance of physicians being aware of all the 
possible variables that contributes to the development, and therefore the anticipation and 
preparation of the disease has proven to save lives. Continuous research in the factors 
involved in the pathophysiological process of neonatal sepsis can uncover methods into 
recognizing and treating the disease. The current evidence shows no one factor that can 
be used to diagnose sepsis, however promising results have been seen when two or more 
of these factors are combined. Experts in the field are continuously attempting to 
establish a set of diagnostic criteria that can be reliable and easily used. However due to 
the lack of consistent evidence in this area, no such list has yet been developed.  
Currently the best methods involved in the investigation of EOS is using the combination 
of maternal risk factors, clinical signs and symptoms, and various laboratory markers that 
are available. It is also highly valuable observing the patients response to treatment, 
further helping guide the next actions that need to be taken. Much has been discovered 
considering the research done thus far on the risk factors, clinical features and laboratory 
results. Yet, the continuous research into the various risk factors and biomarkers needs to 
be continued in order to find a factor or combination of factors in order to make a reliable 
diagnosis that can be used world wide.   
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